CN1115658A - Chinese medicine composite for coronary heart disease and angina - Google Patents

Chinese medicine composite for coronary heart disease and angina Download PDF

Info

Publication number
CN1115658A
CN1115658A CN 94115183 CN94115183A CN1115658A CN 1115658 A CN1115658 A CN 1115658A CN 94115183 CN94115183 CN 94115183 CN 94115183 A CN94115183 A CN 94115183A CN 1115658 A CN1115658 A CN 1115658A
Authority
CN
China
Prior art keywords
radix
content
rhizoma
chinese medicine
heart disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 94115183
Other languages
Chinese (zh)
Other versions
CN1051008C (en
Inventor
韩瑞文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94115183A priority Critical patent/CN1051008C/en
Publication of CN1115658A publication Critical patent/CN1115658A/en
Application granted granted Critical
Publication of CN1051008C publication Critical patent/CN1051008C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The said Chinese medicine composite consists of Astragalus membranaceus 10-20%, red sage 8-16%, Chinese angelica 2-8%, Ligusticum wallichii 2-8%, safflower 4-8%, Rhizoma corydalis 4-12%, Atractylodes macrocephala 6-10%, Trichosanthes kirilowii 7-12%, cassia twig 2-7%, calamus 2-10%, Polygala tenuifolia 2-8%, date kernel 4-10% and licorice root 2-6%. It has high curative rate when used for coronary heart disease and angina.

Description

A kind of treatment coronary heart disease, anginal Chinese medicine composition
The present invention relates to a kind of Chinese medicine composition, particularly a kind of treatment coronary heart disease, anginal Chinese medicine composition.
The current coronary heart disease commonly encountered diseases that become international because this disease is sudden strong, so often have little time treatment during outbreak, uses existing Chinese medicine and western medicine also to be difficult to healing.The Chinese patent medicine of treatment coronary heart disease commonly used has SHANHAI PILL, compound recipe Buxus sinica (Rehd.et Wils.) sheet at present, the former adopts the theoretical point view that nourishes blood with blood in the theory of Chinese medical science and establishes, and is better to treatment blood-deficiency type coronary heart disease curative effect, but cures various types of coronary heart disease with it, curative effect is also not exclusively satisfied, and price is more expensive; And the latter serves as that the master makes tablet with the medicinal part of Buxus sinica (Rehd.et Wils.), but Buxus sinica (Rehd.et Wils.) is the endemicity Chinese herbal medicine, and its pharmacology, nature and flavor, toxic and side effects go into to understand less, and make the fixed tablet of composition again, can not be because of patient's different cause of disease symptomatic treatments.
The object of the present invention is to provide a kind of can be at the dissimilar coronary heart disease of different etiological treatments, recover cardiac function, and cure rate height, Chinese medicine composition that price is low.
Treatment coronary heart disease provided by the invention, anginal Chinese medicine composition include: the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, Fructus Trichosanthis, Ramulus Cinnamomi, Rhizoma Acori Graminei, Radix Polygalae, Semen Ziziphi Spinosae, Radix Glycyrrhizae, and the shared weight ratio of each component is:
Radix Astragali 10-20%
Radix Salviae Miltiorrhizae 8-16%
Radix Angelicae Sinensis 2-8%
Rhizoma Chuanxiong 2-8%
Flos Carthami 4-8%
Rhizoma Corydalis 4-12%
Rhizoma Atractylodis Macrocephalae 6-10%
Fructus Trichosanthis 7-12%
Ramulus Cinnamomi 2-7%
Rhizoma Acori Graminei 2-10%
Radix Polygalae 2-8%
Semen Ziziphi Spinosae 4-10%
Radix Glycyrrhizae 2-6%
Treatment coronary heart disease provided by the invention, anginal Chinese medicine composition at the different causes of disease, can also add the Chinese medicine composition that other composition is made series.One of them can also contain: Rhizoma Zingiberis, Bulbus Allii Macrostemonis, Rhizoma Zingiberis content are that 4-8%, Bulbus Allii Macrostemonis content are 4-12%.
Wherein two can also contain crust halberd, Cortex Cinnamomi, crust halberd content is that 4-15%, Cortex Cinnamomi content are 2-8%.
Wherein three can also contain Radix Scutellariae, Rhizoma Coptidis, Radix Puerariae, Radix Scutellariae content is that 4-12%, Rhizoma Coptidis content are that 4-12%, Radix Puerariae content are 4-12%.
Wherein four can also contain Radix Bupleuri, Radix Gentianae, Concha Haliotidis, Radix Bupleuri content is that 2-8%, Radix Gentianae content are 2-8%, Concha Haliotidis 4-8%.
Wherein five can also contain the Rhizoma Pinelliae, Bulbus Fritillariae Cirrhosae, Rhizoma Pinelliae content is that 2-6%, Bulbus Fritillariae Cirrhosae content are 4-8%.
Wherein six can also contain succinum, Olibanum, Myrrha, succinum content is that 1-4%, Olibanum content are 4-8%, Myrrha 4-12%.
Adopt Chinese medicine composition of the present invention, treat all types of coronary heart disease, angina pectoris, through clinical practice in 5 years, and 150 people are wherein carried out tracing observation, therapeutic effect is obvious, sees table:
The short term effect statistical table
Efficacy evaluation Observe total number of persons Produce effects Improve Invalid Increase the weight of Effectively total
The symptom curative effect Number ????150 ????96 ????50 ????4 ????146
????% ????64 ????33.3 ????2.7 ????97.3
ECG curative effect Number ????150 ????65 ????71 ????14 ????136
????% ????43.4 ????47.3 ????9.3 ????90.7
Warp is to the long-term observation in 3 months-3 years of 94 people in addition, and relapse rate only is 15.9%, truly has the recovery cardiac function thereby further confirmed the present invention, even fundamentally cures all types of coronary heart disease, anginal effect.
The invention has the advantages that, can be at different cause of disease symptomatic treatments, thus cure rate is much higher than other medicines, but also can recover cardiac function, product price is lower simultaneously, can be accepted by extensive patients.
Embodiments of the invention are provided below:
Embodiment 1: the cause of disease belongs to cold coagulation when being main, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 8%, Radix Glycyrrhizae 4%, Rhizoma Zingiberis 6%, Bulbus Allii Macrostemonis 8%, each component weight sum is 100%.Adopt the method for the existing Chinese medicine electuary of purchasing that Chinese medicine composition is made electuary.
Embodiment 2: the cause of disease belongs to cold coagulation when being insufficiency of kidney-YANG in main, then the component with embodiment 1 is adjusted into: Fructus Trichosanthis 7%, Rhizoma Acori Graminei 4%, Radix Polygalae 3%, Rhizoma Zingiberis 4%, Bulbus Allii Macrostemonis 5%, crust halberd 5%, Cortex Cinnamomi 4%, other component and constant rate each component weight sum are 100%.Production method is identical with embodiment 1.
Embodiment 3: when the cause of disease belongs to the pathogenic fire criminal heart, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 8%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 5%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 5%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 6%, Radix Glycyrrhizae 4%, Radix Scutellariae 6%, Rhizoma Coptidis 6%, Radix Puerariae 6%, each component weight sum is 100%.With the existing method for preparing Chinese medicinal tablet Chinese medicine composition is made tablet.
Embodiment 4: the cause of disease belongs to pathogenic fire when violating in the heart flaming up of liver-fire, then the component with embodiment 3 is adjusted into: Radix Angelicae Sinensis 2%, Rhizoma Chuanxiong 5%, Ramulus Cinnamomi 2%, Semen Ziziphi Spinosae 4%, Radix Scutellariae 5%, Rhizoma Coptidis 5%, Radix Puerariae 4%, Radix Bupleuri 4%, Radix Gentianae 4%, Concha Haliotidis 4%, other each component and constant rate, each component weight sum is 100%.Production method is identical with embodiment 3.
Embodiment 5: when the cause of disease belongs to the turbid impatency of expectorant, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 10%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 8%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 8%, Radix Glycyrrhizae 6%, the Rhizoma Pinelliae 4%, Bulbus Fritillariae Cirrhosae 6%, each component weight sum is 100%.With the existing method for preparing Chinese medicinal capsule Chinese medicine composition is made capsule.
Embodiment 6: when the cause of disease belongs to the blood stasis resistance heart, the composition of Chinese medicine composition of the present invention and proportioning are: the Radix Astragali 10%, Radix Salviae Miltiorrhizae 8%, Radix Angelicae Sinensis 5%, Rhizoma Chuanxiong 6%, Flos Carthami 6%, Rhizoma Corydalis 6%, the Rhizoma Atractylodis Macrocephalae 8%, Fructus Trichosanthis 7%, Ramulus Cinnamomi 4%, Rhizoma Acori Graminei 6%, Radix Polygalae 6%, Semen Ziziphi Spinosae 6%, Radix Glycyrrhizae 4%, succinum 2%, Olibanum %, Myrrha 7%, each composition weight sum is 100%.With the existing method for preparing medicine pill Chinese medicine composition is made pill.

Claims (7)

1, a kind of treatment coronary heart disease, anginal Chinese medicine composition comprise: the Radix Astragali, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Flos Carthami, Rhizoma Corydalis, the Rhizoma Atractylodis Macrocephalae, Fructus Trichosanthis, Ramulus Cinnamomi, Rhizoma Acori Graminei, Radix Polygalae, Semen Ziziphi Spinosae, Radix Glycyrrhizae is characterized in that the shared weight ratio of each component is:
Radix Astragali 10-20%
Radix Salviae Miltiorrhizae 8-16%
Radix Angelicae Sinensis 2-8%
Rhizoma Chuanxiong 2-8%
Flos Carthami 4-8%
Rhizoma Corydalis 4-12%
Rhizoma Atractylodis Macrocephalae 6-10%
Fructus Trichosanthis 7-12%
Ramulus Cinnamomi 2-7%
Rhizoma Acori Graminei 2-10%
Select will 2-8%
Semen Ziziphi Spinosae 4-10%
Radix Glycyrrhizae 2-6%.
2, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Rhizoma Zingiberis, Bulbus Allii Macrostemonis, Rhizoma Zingiberis content is 4-8%, and Bulbus Allii Macrostemonis content is 4-12%.
3, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain crust halberd, Cortex Cinnamomi, crust halberd content is 4-15%, Cortex Cinnamomi 2-8%.
4, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Radix Scutellariae, Rhizoma Coptidis, Radix Puerariae, Radix Scutellariae content is that 4-12%, Rhizoma Coptidis content are that 4-12%, Radix Puerariae content are 4-12%.
5, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain Radix Bupleuri, Radix Gentianae, Concha Haliotidis, Radix Bupleuri content is that 2-8%, Radix Gentianae content are that 2-8%, Concha Haliotidis content are 4-8%.
6, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain the Rhizoma Pinelliae, Bulbus Fritillariae Cirrhosae, Rhizoma Pinelliae content is that 2-6%, Bulbus Fritillariae Cirrhosae content are 4-8%.
7, treatment coronary heart disease according to claim 1, anginal Chinese medicine composition is characterized in that: can also contain succinum, Olibanum, Myrrha, succinum content is that 1-4%, Olibanum content are that 4-8%, Myrrha content are 4-12%.
CN94115183A 1994-09-16 1994-09-16 Chinese medicine composite for coronary heart disease and angina Expired - Fee Related CN1051008C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94115183A CN1051008C (en) 1994-09-16 1994-09-16 Chinese medicine composite for coronary heart disease and angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94115183A CN1051008C (en) 1994-09-16 1994-09-16 Chinese medicine composite for coronary heart disease and angina

Publications (2)

Publication Number Publication Date
CN1115658A true CN1115658A (en) 1996-01-31
CN1051008C CN1051008C (en) 2000-04-05

Family

ID=5037388

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94115183A Expired - Fee Related CN1051008C (en) 1994-09-16 1994-09-16 Chinese medicine composite for coronary heart disease and angina

Country Status (1)

Country Link
CN (1) CN1051008C (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005120533A1 (en) * 2004-06-09 2005-12-22 Purimed Co., Ltd. Polygala tenuifolia extract for preventing and treating ischemic heart disease and phar¬ maceutical composition and health food containing the same
CN100339093C (en) * 2005-07-28 2007-09-26 山东中医药大学 Compound medicine for treating coronary heart disease and angina pectoris and its preparing process
CN102641420A (en) * 2012-05-15 2012-08-22 沈长发 Pharmaceutical composition for treating coronary heart disease
CN103638373A (en) * 2013-11-20 2014-03-19 蒋学 Medicine used for treating angina pectoris, and preparation method thereof
CN104352854A (en) * 2014-11-04 2015-02-18 赵国忠 Angina pectoris Yang activating, blood circulation promoting and stasis removing preparation and preparation method thereof
CN104352810A (en) * 2014-10-27 2015-02-18 王志春 Medicine for treating palpitation and preparation method thereof
CN104435853A (en) * 2014-12-19 2015-03-25 李建德 Traditional Chinese medicine composition for treating coronary heart disease
CN104645207A (en) * 2015-03-17 2015-05-27 朱克兰 Traditional Chinese medicine composition for treating angina
CN104873685A (en) * 2015-06-02 2015-09-02 周红玲 Medicine for treating coronary heart disease
CN104922507A (en) * 2015-05-31 2015-09-23 济南邦文医药科技有限公司 Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with diabetes
CN105616804A (en) * 2015-12-30 2016-06-01 杨桂珍 Medicine for treating latent coronary heart disease
CN106421702A (en) * 2016-11-01 2017-02-22 张志明 Traditional Chinese medicine composite for treating coronary heart disease
CN108159213A (en) * 2018-03-27 2018-06-15 南阳理工学院 It is a kind of to be used to treat Chinese medicine composition of coronary heart disease and preparation method thereof
CN111870645A (en) * 2020-07-09 2020-11-03 何庆勇 Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101485832B (en) * 2009-01-19 2011-08-31 陈国来 Capsule for coronary disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1065793A (en) * 1991-04-15 1992-11-04 李文升 A kind of manufacture method of Chinese medicine Zhixindan
CN1082911A (en) * 1993-02-14 1994-03-02 天津市医药工业技术研究所 The new drug of treatment angina pectoris Chinese medicine
CN1028003C (en) * 1993-02-17 1995-03-29 第二炮兵西安中医多学科研究所 Method of preparing medicine for treatment of coronary heart disease

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005120533A1 (en) * 2004-06-09 2005-12-22 Purimed Co., Ltd. Polygala tenuifolia extract for preventing and treating ischemic heart disease and phar¬ maceutical composition and health food containing the same
CN100339093C (en) * 2005-07-28 2007-09-26 山东中医药大学 Compound medicine for treating coronary heart disease and angina pectoris and its preparing process
CN102641420A (en) * 2012-05-15 2012-08-22 沈长发 Pharmaceutical composition for treating coronary heart disease
CN103638373B (en) * 2013-11-20 2015-07-08 蒋学 Medicine used for treating angina pectoris, and preparation method thereof
CN103638373A (en) * 2013-11-20 2014-03-19 蒋学 Medicine used for treating angina pectoris, and preparation method thereof
CN104352810A (en) * 2014-10-27 2015-02-18 王志春 Medicine for treating palpitation and preparation method thereof
CN104352854A (en) * 2014-11-04 2015-02-18 赵国忠 Angina pectoris Yang activating, blood circulation promoting and stasis removing preparation and preparation method thereof
CN104435853A (en) * 2014-12-19 2015-03-25 李建德 Traditional Chinese medicine composition for treating coronary heart disease
CN104645207A (en) * 2015-03-17 2015-05-27 朱克兰 Traditional Chinese medicine composition for treating angina
CN104922507A (en) * 2015-05-31 2015-09-23 济南邦文医药科技有限公司 Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with diabetes
CN104873685A (en) * 2015-06-02 2015-09-02 周红玲 Medicine for treating coronary heart disease
CN105616804A (en) * 2015-12-30 2016-06-01 杨桂珍 Medicine for treating latent coronary heart disease
CN106421702A (en) * 2016-11-01 2017-02-22 张志明 Traditional Chinese medicine composite for treating coronary heart disease
CN108159213A (en) * 2018-03-27 2018-06-15 南阳理工学院 It is a kind of to be used to treat Chinese medicine composition of coronary heart disease and preparation method thereof
CN111870645A (en) * 2020-07-09 2020-11-03 何庆勇 Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof
CN111870645B (en) * 2020-07-09 2022-04-29 何庆勇 Composition for treating coronary heart disease, traditional Chinese medicine composition and application thereof

Also Published As

Publication number Publication date
CN1051008C (en) 2000-04-05

Similar Documents

Publication Publication Date Title
Wang et al. Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine
CN1124153C (en) Medicinal composition for restoring cardiac collaterals and its application
CN101181600B (en) Traditional Chinese medicine composition for curing cardiovascular and cerebrovascular diseases
CN1051008C (en) Chinese medicine composite for coronary heart disease and angina
CN103768537B (en) Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris
CN1224614A (en) Medicine for preventing and curing cardiac and cerebral vascular diseases and its preparation
CN103463568B (en) Traditional Chinese medicine for treating coronary heart disease
CN101028507A (en) Chinese-medicinal composition for treating asthma
CN1840126A (en) Chinese medicine for treating amblyopia and myopia
CN112891399A (en) Traditional Chinese medicine composition and application and preparation method thereof
CN104666951A (en) Traditional Chinese medicine composition for treating parturient paresis puerperal fever
CN110960619A (en) Traditional Chinese medicine composition for treating African swine fever
CN103432503A (en) Traditional Chinese medicine composition
CN1150018C (en) Medicine for treating tachy-arrhythmia
CN1103223C (en) Chinese medicine for treating cholecystitis
CN1931329A (en) Stomatocase treating medicine
CN103656122B (en) Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof
CN104587267A (en) Traditional Chinese medicine composition for treating psoriasis
CN102335336A (en) Traditional Chinese medicine for treating lupus sebaceus
CN1296832A (en) Chinese medicine for treating psoriasis
CN101293083A (en) Pharmaceutical composition and preparation method thereof
CN1331996A (en) Hepatitis B treaitng pill
CN1028605C (en) Series medical health chothes and its making method
CN1365822A (en) 'Shugan Lidan' capsule and its preparing process
CN1256138C (en) Medicine for treating apoplexy and its preparing process

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee